US2017128633A1PendingUtilityA1

Bioactive Implants and Methods of Making and Using

51
Assignee: MALININ THEODOREPriority: Nov 10, 2015Filed: Nov 10, 2015Published: May 11, 2017
Est. expiryNov 10, 2035(~9.3 yrs left)· nominal 20-yr term from priority
A61L 2300/106A61L 27/54A61L 2430/02A61L 27/3608A61L 27/50A61L 2430/06A61L 2300/404A61L 27/3612A61L 31/048A61L 31/044A61L 31/041A61L 31/16A61L 31/043
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present application relates to bioactive implants, methods of making bioactive implants, and methods of using bioactive implants to treat or repair a bone defect or a cartilage defect. In an aspect, the present application relates to compositions comprising bone microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, the present application relates to compositions comprising cartilage microparticles in a solution, wherein the compositions harden upon desiccation into bioactive implants. In an aspect, disclosed herein are methods of making and using the disclosed compositions comprising bone microparticles and the disclosed composition comprising cartilage microparticles. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claims

exact text as granted — not AI-modified
1 . A composition, comprising: cartilage microparticles in a solution comprising povidone iodine, wherein the size of the cartilage microparticles is from about 50 μm to about 900 μm, and wherein the composition is configured to harden upon desiccation into a bioactive implant. 
     
     
         2 . The composition of  claim 1 , wherein the hardened bioactive implant has a predetermined size and shape. 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . The composition of  claim 1 , wherein the composition comprises about 25% w/v of cartilage microparticles. 
     
     
         6 . The composition of  claim 1 , wherein the solution comprises a solvent and wherein the solvent comprises water, saline, or a balanced salt solution. 
     
     
         7 . The composition of  claim 1 , further comprising: an agent, wherein the agent comprises one or more of a therapeutic agent, a bone morphogenetic protein, an anti-infective agent, a growth factor, a growth hormone, an antibiotic, an analgesic, a vitamin, a sterilizing agent, or a combination thereof. 
     
     
         8 . The composition of  claim 1 , wherein the bioactive implant is chondrogenic. 
     
     
         9 . A bioactive implant made by a method comprising: desiccating a composition comprising cartilage microparticles in a solution comprising povidone iodine, wherein the size of the cartilage microparticles is from about 50 μm to about 900 μm, wherein the hardened bioactive implant has a predetermined size and shape. 
     
     
         10 . (canceled) 
     
     
         11 . The bioactive implant of  claim 9 , wherein the composition comprises about 25% w/v of cartilage microparticles. 
     
     
         12 . The bioactive implant of  claim 9 , wherein the cartilage microparticles are evenly embedded in the implant. 
     
     
         13 . The bioactive implant of  claim 9 , wherein the bioactive implant is chondrogenic. 
     
     
         14 . A method of preparing a bioactive implant, the method comprising:
 desiccating a composition comprising cartilage microparticles in a solution comprising povidone iodine, wherein the size of the cartilage microparticles is from about 50 μm to about 900 μm.   
     
     
         15 . The method of  claim 14 , wherein desiccating comprises producing a hardened bioactive implant having a predetermined size and shape. 
     
     
         16 . (canceled) 
     
     
         17 . The method of  claim 14 , wherein the composition comprises about 25% w/v of cartilage microparticles. 
     
     
         18 . The method of  claim 14 , wherein desiccating the composition comprises freeze-drying the composition. 
     
     
         19 . The method of  claim 14 , wherein desiccating the composition comprises subjecting the composition to hypothermic dehydration. 
     
     
         20 . The method of  claim 14 , comprising: preparing the composition, wherein preparing the composition comprises adding cartilage microparticles to a solvent to generate the solution. 
     
     
         21 . The composition of  claim 1 , wherein the cartilage microparticles comprise decalcified cartilage microparticles.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.